Avantor, Inc. (NYSE:AVTR) Shares Sold by ASB Consultores LLC

ASB Consultores LLC reduced its stake in Avantor, Inc. (NYSE:AVTR) by 27.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 10,161 shares of the company’s stock after selling 3,895 shares during the quarter. ASB Consultores LLC’s holdings in Avantor were worth $215,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in AVTR. Versant Capital Management Inc lifted its stake in Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. boosted its holdings in Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after acquiring an additional 1,391 shares during the period. TFO Wealth Partners LLC boosted its holdings in Avantor by 203,100.0% during the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock valued at $46,000 after acquiring an additional 2,031 shares during the period. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new stake in Avantor during the first quarter worth about $93,000. Finally, ORG Partners LLC lifted its position in shares of Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock worth $122,000 after purchasing an additional 5,773 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on AVTR shares. Robert W. Baird lifted their price objective on shares of Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a report on Monday, July 29th. Barclays upped their price objective on Avantor from $25.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Royal Bank of Canada reiterated an “outperform” rating and issued a $31.00 price objective on shares of Avantor in a research note on Monday, July 29th. Wells Fargo & Company started coverage on Avantor in a report on Tuesday, August 27th. They set an “overweight” rating and a $30.00 price target on the stock. Finally, Stifel Nicolaus lifted their price objective on Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Avantor presently has a consensus rating of “Moderate Buy” and an average price target of $27.40.

Insider Buying and Selling

In other news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 1.50% of the company’s stock.

Avantor Stock Down 2.6 %

Avantor stock opened at $26.99 on Friday. The company has a market capitalization of $18.33 billion, a P/E ratio of 69.21, a PEG ratio of 2.75 and a beta of 1.32. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $28.00. The stock has a 50-day simple moving average of $25.04 and a 200-day simple moving average of $24.36.

Avantor (NYSE:AVTR) last announced its earnings results on Friday, July 26th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. The business had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a net margin of 5.28% and a return on equity of 12.40%. Equities research analysts expect that Avantor, Inc. will post 1.01 earnings per share for the current year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.